Non-invasive Measurement of Arterial Stiffness
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Dec 7, 2022
Trial Information
Current as of February 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to measure arterial stiffness, which is important for predicting heart-related issues that can happen during or after surgery. The researchers have developed a method to continuously estimate a specific measurement called Carotid-Femoral Pulse Wave Velocity (PWVcf) using standard monitoring tools already used in the operating room, like an electrocardiogram (ECG) and a non-invasive blood pressure monitor. This new approach aims to make it easier for doctors to assess a patient's heart health without needing complex equipment.
To participate in this study, you need to be at least 18 years old and scheduled for a surgery that requires general or local anesthesia. If you have certain conditions, such as specific heart rhythm issues or severe circulation problems in your legs, you may not be eligible. If you join the trial, you can expect to have your heart health monitored during your surgery using the new method, which is completely non-invasive and safe. Your participation will help researchers find out if this new measurement technique can be a reliable tool for improving patient care in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients of legal age ( 18 years)
- • Eligible for a scheduled surgical procedure under general or locoregional anesthesia.
- • Patients who have expressed no objection to participating in this research
- Exclusion Criteria:
- • Patients under 18 years of age.
- • Carotid or femoral space not available
- • Atrial fibrillation arrhythmia (AFA)
- • Advanced obliterative arteriopathy of the lower limbs (grade III and IV - Leriche and Fontaine)
- • Patient opposed to participation in the protocol
- • Pregnant woman
- • Patient under judicial protection
- • Patient not affiliated to a social health system
Trial Officials
Joaquim MD MATEO
Study Director
Assistance Publique - Hôpitaux de Paris
Fabrice MD VALLEE, PhD
Principal Investigator
Assistance Publique - Hôpitaux de Paris, Department of Anesthesiology and Intensive Care
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials